-
StrideBio, Takeda Pair to Develop Adeno-Associated Viruses for Friedreich’s Ataxia Gene Therapies
Takeda and StrideBio have set out to develop more effective adeno-associated viruses (AAV) to be used as vehicles for in vivo delivery of gene therapies. Learn more about this project here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.